Primary cardiac sarcoma is a rare malignant myocardial neoplasm that does not exhibit gender predominance or age predilection. The classification of these tumors includes several subtypes, of which synovial sarcoma is a rare manifestation. When present, these tumors portend a poor prognosis with high morbidity and mortality that is attributable to their inherent infiltrative capacity, especially in the absence of treatment. The general consensus for treatment is surgical excision and neoadjuvant chemotherapy and radiotherapy. In this report, a case of synovial sarcoma involving the left ventricular outflow tract and aortic valve is presented.
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2iHyb2N
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Nephrolithiasis accelerates the renal failure in the patients with ADPKD. In order to evaluate the role of percutaneous nephrolithotomy in m...
-
A mass-change-based method based on output-only data for the rescaling of mode shapes in operational modal analysis (OMA) is introduced. The...
-
by Maggie Zgambo, Balwani Chingatichifwe Mbakaya, Fatch Welcome Kalembo Background Malaria is the main cause of morbidity and mortality amo...
-
Voice alterations in patients with Morquio A syndrome. J Appl Genet. 2017 Dec 23;: Authors: Szklanny K, Gubrynowicz R, Tylki-Szymańsk...
-
Cancer Cytopathology Mark above section as read Case Reports in Pathology Mark above section as read Clinical Anatomy Mark above section as ...
-
Student accommodation. St John's is proud of its centrally-located student accommodation, which is among the most affordable in the Univ...
-
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2o3fxRd via IFTTT
-
Free Cry the Beloved Country papers, essays, and research papers. from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader ht...
-
Share | © , 2003-2017, #4## | About | 2257 | DMCA | Privacy Policy | Terms of Use | News | Advanced Search | Advertisers | Feedback from #...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου